Thursday, July 23, 2009
New Study Shows Agent Can Improve Muscle Strength, Size, in Mouse ALS Model
click on the link above for information about a phase I trial at Johns Hopkins' ALS Packard Center in Baltimore of a new agent which is believed to slow down muscle-wasting in ALS patients.
Subscribe to:
Post Comments (Atom)
1 comment:
Those are SOD1 mice, and most of us human pALS (90%+) have sporadic ALS.
(Mary Jo from Canada)
Post a Comment